How an on-hold Ebola treatment is boosting Tekmira

August 4, 2014 4:15 PM

12 0

With the Ebola outbreak in West Africa proving difficult to control, according to Centers for Disease Control and Prevention director Tom Frieden, the world is looking to the pharmaceutical industry for solutions.

That's pushing up shares of a money-losing Canadian biotech firm called Tekmira Pharmaceuticals (TKMR), which has been working on a treatment called TKM-Ebola. The stock jumped by almost one-third last week, and rose another 12 percent in early trading on Monday, before slipping back along with the ...

Also read: Devs React: Nintendo unveils its hybrid-handheld console Switch

Read more

To category page